J&J’s Innovative Medicine business continued its solid growth in the second quarter of 2025 with sales rising 4.9% year over ...

Revised Phase 2 Strategy Targets Event-Free Survival in Primary Head and Neck Cancer through Checkpoint Inhibitor Combination ...

If you're looking for something other than aspirin to relieve a headache, experts say you should consider what's on your ...

With nearly half of all pregnancies worldwide being unintended, the need for effective, reversible male contraceptives ...

Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the ...

Discover how CRISPR gene editing is creating personalized cancer therapies, enhancing immunotherapy, and offering new hope ...

Precision cancer treatment on a larger scale is moving closer now that researchers have developed an AI platform to tailor ...

A team used generative AI to enhance T cells’ ability to fight melanoma. The immunotherapy approach needs more testing before use in cancer patients.

Researchers have demonstrated that microscopic drug delivery containers can be magnetically steered to their targets, ...

Li, Huang, and Sirota chose 2 cancer drugs out of the top 5 drug candidates for laboratory testing. They predicted one drug, ...

DelveInsight’s, “ Small Lymphocytic Lymphoma Pipeline Insight, 2025 ” report provides comprehensive insights about 80+ ...

Relevant biomarkers include cytokines and targets such as IL-4, IgE, IL-5, IL-13, IL-33, and TSLP (Figure 2). A number of targeted drugs are currently available, including lebrikizumab, dupilumab, and ...